557 Views

To Earn CE for this Session: Watch the on-demand recording in its entirety in one sitting to unlock the CE quiz. Then click here to complete the CE quiz for this session.

Technician Session

Oncology

Compounding Pharmaceuticals in Veterinary Medicine

Friday, June 24, 2022

1:30 PM – 2:30 PM CT

Location: ACC 4ABC

CE: 1

Sponsored by

Primary Presenter(s)

Philip J. Bergman, DVM, MS, PhD, DACVIM (Oncology)

Director, Clinical Studies
VCA
Katonah, NY, New York, United States

Proceedings/Handout

This presentation will review the scientific literature concerning compounding in veterinary medicine. It will concentrate on compounding in veterinary oncology, but will also present the scientific literature around compounding in small animal internal medicine, neurology and some large animal compounding publications. It will also review and define the word salad with compounding such as PCAB, USP statutes and pay particularly close attention to 503A vs 503B designations and their impact on compounding.

Learning Objectives:

Develop an understanding of PCAB, USP 795, USP 797, USP 800 and then 503A vs 503B
Understand and appreciate the differences between 503A vs 503B compounding pharmacies
Become aware of the significant scientific literature around veterinary compounding and the impact it may have on the dose delivered to our patients compared to what was prescribed